Research 2025: CBN May Support Calmer Nights and Fewer Awakenings

Cannabinol (CBN) has long been regarded as a relatively unknown and less-studied cannabinoid, often overshadowed by THC and CBD. That picture is now beginning to change. New research findings from both animal studies and human pilot trials suggest that CBN may influence sleep duration and sleep architecture in several notable ways. From increased deep sleep in laboratory settings to fewer nighttime awakenings among study participants, the research indicates that this degradation product of THC deserves greater attention in the scientific discussion on sleep and recovery.

What Is CBN?

CBN, or cannabinol, is a naturally occurring compound formed when THC breaks down over time. This is why older cannabis flowers often contain higher levels of CBN than fresh ones. Unlike THC, CBN is only mildly psychoactive, which has given it a distinct position in research as a cannabinoid with potentially specific effects, particularly in areas such as sleep and neurological health.

Historically, CBN was viewed primarily as a “degradation product” rather than an active compound of interest, but that perception has shifted in recent years. An increasing number of research groups are now examining its pharmacology and potential applications.

Animal Research – Improved Sleep Architecture and Longer Total Sleep Time

  • One of the most widely noted research contributions comes from the University of Sydney, where researchers in 2024 published results from a carefully controlled study on rats.

    By using EEG monitoring—the same type of method employed in clinical sleep studies in humans—the researchers were able to measure precisely how CBN affected different stages of sleep. The results showed that the rats experienced:

    • Increased NREM sleep (deep sleep)
    • More REM sleep, which is important for memory consolidation and emotional regulation
    • Extended total sleep time compared to the control group

    The researchers also found that a metabolite of CBN, known as 11-hydroxy-CBN, showed stronger binding to the brain’s CB₁ receptors than CBN itself. This is notable, as it suggests that CBN’s effects may partly depend on how the body metabolizes and converts the compound.

    Dr. Peter Kevin, one of the researchers behind the study, commented that the effects were “comparable to the prescription sleep medication zolpidem” in certain respects—making the findings particularly interesting for further research.

Human Pilot Studies – Fewer Nighttime Awakenings

When it comes to humans, the research is still in its early stages, but there are already some interesting findings. A double-blind, placebo-controlled Phase II study from 2022 examined the effects of 20 mg of CBN in adults with self-reported sleep difficulties.

The participants were divided into two groups:

  • One group received CBN as a single dose before bedtime
  • The other group received a placebo

The results showed that the CBN group, on average, woke up fewer times during the night (approximately 0.5 fewer awakenings per night) compared to the placebo group. However, the subjective perception of overall sleep quality did not improve significantly—something the researchers suggest may be due to the relatively short study duration and small sample size.

Although the findings do not provide a complete picture, they indicate that CBN may have an effect on sleep continuity, meaning the ability to sleep without disruption throughout the night.

Possible Mechanisms Behind CBN’s Effects

The exact mechanism of action of CBN is not yet fully understood, but current research points to several possible explanations:

  1. Low affinity for the CB₁ receptor – CBN binds weakly to the receptor that THC activates strongly, which may result in mild, attenuated effects without pronounced psychoactivity.
  2. Interaction with CB₂ receptors – this may influence the body’s immune and inflammatory systems, which in turn could indirectly affect sleep.
  3. Metabolite activity – certain breakdown products, such as 11-hydroxy-CBN, appear to exhibit higher biological activity than the parent compound.
  4. Interaction with other signaling systems – there are indications that CBN may affect TRPV channels and serotonin receptors, both of which are involved in sleep regulation.

How CBN Differs from CBD and THC

Many people are familiar with CBD and THC, but CBN has a distinct profile:

CharacteristicTHCCBDCBN
PsychoactivityHighNoneVery low
Sleep researchSome evidenceMixed resultsEarly positive signals
OriginDirectly from the plantDirectly from the plantDegradation of THC
Status in EuropeRegulated (not legal)Legal (<0.3% THC)Not specifically regulated

The International Research Landscape

During 2024 and 2025, interest in CBN has increased across several research environments:

  • United States – clinical trials are underway examining CBN and sleep, including studies involving shift workers and older adults with age-related sleep issues.
  • Europe – pilot projects in Switzerland are incorporating CBN into product profiles to assess how users report differences in experience.
  • Australia – several universities have launched preclinical studies to map CBN’s effects on neurodegeneration and circadian rhythms.

Important to Emphasize

Despite promising results from both animal and human studies, research on CBN is still in its early stages. Most studies are small and short-term, meaning the findings should be interpreted with caution. Researchers agree that larger, long-term studies are needed before firm conclusions can be drawn about CBN’s role in sleep-related issues.

Common Questions About CBN and Sleep

(Compiled by Raw Hemp based on published research)
CBN is a cannabinoid that forms when THC breaks down, often during storage. It is milder than THC and lacks many of its stronger psychoactive effects.
Animal studies show improved sleep architecture and longer total sleep time. Human pilot studies suggest fewer nighttime awakenings, but the results are still preliminary.
CBD has primarily been studied in relation to falling asleep and anxiety-related sleep issues. CBN is less explored, and the research is still at an early stage.
The studies report few and mild side effects, such as fatigue or dizziness. More data is needed to confirm the safety profile.
In the human pilot study, 20 mg of CBN was administered before bedtime. The animal studies used equivalent doses adjusted for body weight.
CBN itself is not classified as a narcotic, but the THC content in a product must not exceed 0.3%.

Sources:
New CBN Sleep Study Shows Meaningful Improvement in Sleep Quality

A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality

Disclaimer: The information in this article is a summary of scientific research and is intended for general informational purposes only. It should not be interpreted as medical advice, diagnosis, or treatment. Always consult a physician or other qualified healthcare professional before starting or changing any treatment.

Related posts

Rulla till toppen